From Anti-Ageing to Geroscience
For decades, 'anti-ageing' has been the domain of cosmetics and supplements. But a more serious field, known as geroscience, is gaining momentum. This area of research operates on a powerful hypothesis: if you target the biological processes of ageing itself,
you can delay or prevent many chronic diseases at once. The World Health Organization has even adopted the term 'ageing-associated decline in intrinsic capacity' to focus on function, rather than just classifying old age as a disease. Instead of tackling cancer, heart disease, and dementia one by one, geroscience researchers aim to treat their biggest shared risk factor: the ageing process. This represents a fundamental shift in medicine, moving from fighting individual illnesses to strengthening the body's resilience over time.
The Rise of Healthspan
A key concept in this new approach is 'healthspan' — the number of years we live in good health, free from chronic disease and disability. This is distinct from 'lifespan', which is simply how long we live. The global focus is gradually shifting from merely living longer to living better. After all, adding years to life is less meaningful if those years are spent in poor health. Research increasingly focuses on compressing the period of illness at the end of life, allowing people to remain functional and independent for as long as possible. This goal has reshaped how scientists study ageing, prioritising quality of life over sheer duration.
Clearing Out 'Zombie' Cells
One of the most promising areas of geroscience involves cellular senescence. As we age, some of our cells stop dividing but refuse to die, earning them the nickname 'zombie cells'. These senescent cells accumulate in tissues and secrete a cocktail of inflammatory substances that can damage nearby healthy cells. This chronic inflammation is linked to a host of age-related conditions, from heart disease to arthritis and dementia. Researchers are now developing and testing drugs called 'senolytics', which are designed to selectively find and destroy these zombie cells. In animal studies, clearing senescent cells has been shown to improve cardiac function, reduce frailty, and enhance physical endurance. Early human trials are underway for various conditions, showing the potential of this approach.
Can We Rewind the Epigenetic Clock?
Another exciting frontier is epigenetic reprogramming. Your DNA is not your destiny; epigenetics refers to the chemical marks on your DNA that tell your genes when to switch on or off. These patterns change as we age, and scientists can measure them to determine your 'biological age', which can be older or younger than your chronological age. The groundbreaking discovery was that these epigenetic marks are reversible. Researchers have shown in labs that by using specific proteins known as 'Yamanaka factors', they can reprogram cells to a more youthful state, effectively resetting their biological clock without erasing their identity. While still in early stages, some studies have even reversed cellular aging by decades in a lab setting and restored vision in animal models, with the first human trials for eye diseases beginning.
No Single 'Cure' in Sight
Despite these incredible advances, scientists are clear that there will not be a single pill to 'cure' ageing. Ageing is a complex process involving multiple interconnected factors, from cellular damage and inflammation to metabolic changes and genetic predispositions. The goal of geroscience is not immortality or a cosmetic fountain of youth. Instead, the focus is on developing interventions that can target the fundamental drivers of ageing to prevent or delay the onset of multiple diseases simultaneously. This might mean a future where people receive a combination of therapies to boost resilience, clear out senescent cells, and maintain youthful cellular function, leading to a longer, healthier life. The real revolution is in treating ageing as a treatable medical condition, which could fundamentally change healthcare in the coming decades.
